Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

TEHRAN - At a conference on commercial opportunities between Iran and India, held on the sidelines of Iran Expo 2025, ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

June 18 is the next deadline to submit your application to the Catalyze product definition program. To ensure you are prepared to submit a compelling application within the scope of Catalyze, join ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Request To Download Free Sample of This Strategic Report  @   This country research report on Vietnam Market offers comprehensive insights into the market landscape, customer intelligence, and ...

However, in March, after settling a $30 million lawsuit over a data breach, 23andMe declared bankruptcy and announced they ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

Rezolute has done well to continue to advance its lead drug from its pipeline, ersodetug. Click here to see why RZLT stock is ...

On April 25, student teams representing every academic department on campus presented the results of their senior theses ...

In recognition of ALS Awareness Month this May, Target ALS is proud to launch Behind Every Breakthrough—a month-long ...